TERT and breast carcinoma: In fact, a recent study has found that telomerase activity, but not telomere length, is decreased in breast cancer survivors even years after cessation of therapy [23], underlying the disconnection between the traditional chromosomal role of telomerase reverse transcriptase (TERT) and its emerging non-canonical functions.